HIV Now: New and Emerging First-line ART Strategies

Expert faculty provide insights on the latest data from studies evaluating recently approved and newly emerging regimens for first-line ART and assess how these new options may fit into evolving HIV treatment paradigms.
Eric S. Daar, MD
Daniel R. Kuritzkes, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 426 KB
Released: December 19, 2018

Acknowledgements

Provided by Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by an educational grant from
Gilead Sciences

Related Content

From CCO: Susan Schrimpf Davis, DO; Cynthia J. Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD; Deborah A. Milito, PharmD, BCGP, FASCP, discuss the importance of vaccinating older adults against shingles and how to overcome common clinical challenges

Susan Schrimpf Davis, DO Cynthia J. Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Deborah A. Milito, PharmD, BCGP, FASCP Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: October 22, 2020 Expired: October 21, 2021

In this CCO commentary, Drs. Chinazo Cunningham and Tiffany Lu outline how HCV and HIV clinicians can integrate OUD care into their clinical practice

Chinazo Cunningham, MD, MS Tiffany Lu, MD, MS Released: October 22, 2020

Susan Schrimpf Davis, DO Released: October 7, 2020

CCO commentary by Dr. Jenna Butner on the importance of and strategies for incorporating HIV risk counseling into substance use disorder care

Jenna Butner, MD Released: August 24, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue